Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.170
-0.110 (-4.82%)
Nov 20, 2026, 12:39 PM EST - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $97.24 million as of November 20, 2026. It is the 24,757th most valuable company in the world and the 4,003rd biggest in the United States. Its market cap has decreased by 48.30% in one year.
Market Cap
97.24M
Enterprise Value
89.14M
1-Year Change
-48.30%
Global Rank
Country Rank
#4,003 United States
Category
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $97.24M, a decrease of -31.37%. That is a compound annual growth rate of -9.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 97.24M | -40.71% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 (IPO) | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 105.65M |
| LENZ Therapeutics | 104.94M |
| Unicycive Therapeutics | 103.02M |
| NovaBridge Biosciences | 102.06M |
| ImmuCell | 101.45M |
| Immunic | 100.83M |
| Canton Strategic Holdings | 100.42M |
| Voyager Therapeutics | 100.19M |